The impact of PAP therapy first impression on short-term treatment adherence
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03320-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Monica Amendolara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University "Aldo Moro", 70124, Bari, Italy. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Sleep Apnea, Obstructive, Patient Compliance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Bari Aldo Moro.
Abstract (Originalsprache)
Purpose
Positive airway pressure (PAP) treatment for obstructive sleep apnea syndrome (OSAS) is often burdened by lower adherence rates. Patients’ perception and acceptance of PAP therapy play a crucial role in achieving acceptable adherence.
Method
We conducted a prospective cohort study to assess patients’ initial impressions of PAP therapy using a six-item questionnaire. The questionnaire evaluated CPAP tolerance, interface comfort, titration pressure, likelihood of CPAP use, expected health benefits, and overall attitude toward PAP therapy. Patients underwent a baseline awake PAP therapy trial (T0) followed by titration with an automatic device (APAP). After one month of titration, a fixed CPAP value was set (T1). Follow-ups occurred at 1 (T2), 3 (T3), and 6 (T4) months after the start of treatment. Adherence to PAP therapy was considered sufficient if the mean device usage was ≥ 4 h/night at T4.
Results
After six months, 77% of the enrolled patients achieved high PAP treatment adherence. Questionnaire scores generally improved from T0 to T4, particularly in CPAP tolerance, likelihood of treatment adherence, expected health benefits, and overall judgment of PAP therapy. Time-to-event analysis revealed that higher baseline scores in titration pressure comfort, likelihood of CPAP adherence, and overall judgment of PAP therapy were significantly associated with higher adherence likelihood.
Conclusion
Patients’ first judgement on PAP therapy could significantly influence short-term adherence. Early identification and management of patients’ complaints and discomforts could improve adherence rates and PAP perception over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University "Aldo Moro", 70124, Bari, Italy.
- Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University "Aldo Moro", 70124, Bari, Italy. andrea.portacci@uniba.it.
ORCID-Profile: Andrea Portacci
Förderung
- Università degli Studi di Bari Aldo Moro
Zitieren
APA
Amendolara, M., Di Lecce, V., Santomasi, C., Quaranta, V. N., Portacci, A., Lazzaretti, I. D., Cuccaro, L. A. S., Casparrini, M., Spierto, S., Picerno, V., De Robertis, C., Quaranta, S., Dragonieri, S., & Carpagnano, G. E. (2025). The impact of PAP therapy first impression on short-term treatment adherence. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03320-4
Vancouver
Amendolara M, Di Lecce V, Santomasi C, Quaranta VN, Portacci A, Lazzaretti ID, et al. The impact of PAP therapy first impression on short-term treatment adherence. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03320-4
BibTeX
@article{Amendolara2025,
author = {Amendolara, Monica and Di Lecce, Valentina and Santomasi, Carla and Quaranta, Vitaliano Nicola and Portacci, Andrea and Lazzaretti, Ilaria Dei and Cuccaro, Laura Anna Sara and Casparrini, Massimo and Spierto, Sebastiano and Picerno, Vito and De Robertis, Cristina and Quaranta, Sara and Dragonieri, Silvano and Carpagnano, Giovanna Elisiana},
title = {The impact of PAP therapy first impression on short-term treatment adherence},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03320-4}
}
EUVIMED